CONDENSED STATEMENT OF CASH FLOWS	3 Months Ended
	Mar. 31, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (202,566)
Adjustments to reconcile net income to net cash used in operating activities:
Investment income earned on treasury securities held in Trust Account	(1,719)
Costs associated with warrant liabilities	488,025
Gain on change in fair value of derivative liabilities	(335,000)
Changes in operating assets and liabilities:
Prepaid expenses	(316,100)
Non-current assets	(287,500)
Accounts payable and accrued expenses	20,751
Net Cash Used In Operating Activities	(634,109)
Cash Flows From Investing Activities:
Cash deposited into Trust Account	176,750,000
Net Cash Used In Investing Activities	(176,750,000)
Cash Flows From Financing Activities:
Sale of Units in Public Offering, net of underwriting discount	171,500,000
Sale of Private Placement Warrants to Sponsor	7,250,000
Proceeds from Sponsor promissory note	70,093
Repayment of Sponsor promissory note	(71,093)
Payment of offering costs	(560,562)
Net Cash Provided By Financing Activities	178,188,438
Net change in cash and cash equivalents	804,328
Cash and cash equivalents at beginning of period	25,000
Cash and cash equivalents at end of period	829,328
Supplemental disclosure of non-cash financing activities:
Change in value of common stock subject to possible redemption	152,653,885
Deferred underwriting compensation	$ 6,125,000